Survival of patients with chronic obstructive pulmonary disease receiving long-term domiciliary oxygen therapy

The American Review of Respiratory Disease
K Ström

Abstract

Previous trials, in which 76 to 100% of the patients were men, have shown a varied survival time in chronic obstructive pulmonary disease treated with long-term domiciliary oxygen therapy. We have analyzed predictors of survival in chronic obstructive pulmonary disease, including sex-related differences in survival in 403 patients (201 men) registered in a national register when starting long-term oxygen therapy between January 1, 1987 and June 30, 1989. This register covers the whole of Sweden with a population of 8.4 million. Some 90% of all the patients receiving long-term oxygen therapy are included. Lung function and performance status predicted survival during oxygen therapy in men, whereas a poor performance status and the presence of orally administered steroid medication predicted poor survival in women. Oral steroid medication use was correlated with an increased mortality rate in women (relative risk of death, 2.13; 95% confidence interval, 1.38 to 3.29; p < 0.001) and showed no tendency to improve survival in men. In patients not receiving oral steroids, women had a lower mortality rate than did men (relative risk of death, 0.58; 95% confidence interval, 0.39 to 0.97; p < 0.05). Our data indicate that in patients no...Continue Reading

References

Oct 1, 1990·Chest·T L Petty, W J O'Donohue
Jan 1, 1990·The American Review of Respiratory Disease·J A LeechJ Gay
Jan 1, 1988·Journal of Clinical Epidemiology·M C Wu, S Eriksson
Jan 1, 1986·The American Review of Respiratory Disease·N R AnthonisenJ E Hodgkin
Jun 26, 1986·The New England Journal of Medicine·B L Riggs, L J Melton
Jan 1, 1985·Respiration; International Review of Thoracic Diseases·R KellerP Borer
Feb 20, 1969·The New England Journal of Medicine·B Burrows, R H Earle
May 1, 1983·Respiration; International Review of Thoracic Diseases·J GłuskowskiJ Zieliński
Mar 1, 1982·Clinical Science·J M Richens, P Howard
Dec 1, 1981·Journal of Steroid Biochemistry·B E NordinR G Crilly

❮ Previous
Next ❯

Citations

Jan 9, 1999·Burns : Journal of the International Society for Burn Injuries·T MuehlbergerL Wong
Jul 10, 2008·International Journal of Antimicrobial Agents·M Balter, R F Grossman
May 17, 2000·Current Opinion in Pulmonary Medicine·J Zieliński
Jan 27, 2007·Current Opinion in Pulmonary Medicine·Philip O'Reilly, William Bailey
Jul 9, 1998·American Journal of Respiratory and Critical Care Medicine·A AidaY Kawakami
Jan 5, 1999·American Journal of Respiratory and Critical Care Medicine·R KesslerE Weitzenblum
Apr 9, 2008·American Journal of Respiratory and Critical Care Medicine·Maria-Christina L Machado
Dec 1, 1996·American Journal of Respiratory and Critical Care Medicine·H A KerstjensD S Postma
Jun 17, 2006·American Journal of Respiratory and Critical Care Medicine·Maria-Christina L MachadoWilliam M Vollmer
Apr 15, 2006·American Journal of Respiratory and Critical Care Medicine·Thomas L Croxton, William C Bailey
Jan 19, 2013·American Journal of Respiratory and Critical Care Medicine·Magnus P EkströmKerstin E Ström
Aug 1, 2012·International Journal of Chronic Obstructive Pulmonary Disease·Ilda GodoyIrma Godoy
Jul 1, 2005·Treatments in Respiratory Medicine·Sat Sharma, Nicholas Anthonisen
Nov 27, 2007·European Journal of Epidemiology·Cynthia de LuiseHenrik Toft Sørensen
Sep 15, 2009·Chest·Magnus EkströmKerstin E Ström
Apr 15, 2015·Thorax·Maxine HardingeUNKNOWN British Thoracic Society Standards of Care Committee
Apr 29, 1998·Chest·R Wilson
Dec 24, 1997·Chest·R Wilson, C B Wilson
Dec 7, 2007·Archivos de bronconeumología·Juan José Soler Cataluña, Miguel Angel Martínez García
Oct 21, 1998·Infectious Disease Clinics of North America·M Niroumand, R F Grossman
Oct 28, 2011·The American Journal of Medicine·Shelley R SalpeterBrad Stuart
Jan 20, 1998·Lancet·J H Dark
May 16, 2000·Journal of the American Geriatrics Society·J LynnE P McCarthy
Jun 8, 2014·Respiratory Medicine·Thomas J RingbaekPeter Lange
Nov 5, 2008·Respiratory Medicine·Torbjörn GustafsonKerstin Ström
Apr 30, 2017·Expert Review of Respiratory Medicine·F S MagnetW Windisch
Feb 1, 2006·Expert Review of Pharmacoeconomics & Outcomes Research·Sabina A Antoniu
Dec 13, 2017·Current Opinion in Pulmonary Medicine·Vivek N Iyer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.